Hua Medicine raises $25 mln
Hua Medicine said Thursday it closed $25 million in Series B financing led by Ally Bridge Group. New investors Frontline BioVentures and TF Capital joined in the round, as well as existing Series A investors ARCH, Venrock, Fidelity, WuXi Ventures, and SAIL. Shanghai-based Hua Medicine is a clinical-stage biotechnology company.
9 January 2015•5 mins read
